What's Going On With Hims & Hers Health Stock? - Benzinga

Jan 9, 2025 · According to data from Benzinga Pro, Hims & Hers has a 52-week high of $35.02 and a 52-week low of $8.14. It closed Wednesday down more than 7% at $25.73. Now Read:

7%
OFF

What's Going On With Hims & Hers Health Stock? - Benzinga

1 week from now

Jan 9, 2025 · According to data from Benzinga Pro, Hims & Hers has a 52-week high of $35.02 and a 52-week low of $8.14. It closed Wednesday down more than 7% at $25.73. Now Read:

benzinga.com

90%
OFF

Hims & Hers Health Are Falling Today: What's Going On?

1 week from now

Dec 19, 2024 · The FDA announced that the tirzepatide injection shortage is resolved. Hims & Hers Health, Inc.'s stock fell 6.90%, reflecting market concerns over regulatory updates and …

benzinga.com

54%
OFF

Spotlight On Hims & Hers Health: Analyzing The Surge In ... - Nasdaq

1 week from now

Nov 27, 2024 · Current Position of Hims & Hers Health With a trading volume of 21,362,792, the price of HIMS is down by -0.54%, reaching $30.52. Current RSI values indicate that the stock …

nasdaq.com

$22.17
OFF

In-Depth Examination Of 6 Analyst Recommendations For Hims

1 week from now

Oct 21, 2024 · Analysts have recently evaluated Hims & Hers Health and provided 12-month price targets. The average target is $22.17, accompanied by a high estimate of $25.00 and a low …

nasdaq.com

39%
OFF

What's Going On With Hims & Hers Health Stock Tuesday?

1 week from now

Nov 5, 2024 · Hims Price Action: Hims & Hers shares were up 5.39% at $21.89 at the time of writing, according to Benzinga Pro. Read Next: ‘30% Less Than Blue’: Swing State Home …

benzinga.com

$375
OFF

What's Going On With Hims & Hers Health Stock Monday?

1 week from now

Nov 4, 2024 · Hims & Hers Health guided for third-quarter revenue of $375 million to $380 million and raised guidance for the full year from a range of $1.2 billion to $1.23 billion to a new range …

benzinga.com

$24
OFF

Assessing Hims & Hers Health: Insights From 7 Financial Analysts

1 week from now

Nov 6, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Hims & Hers Health, presenting an average target of $24.0, a high estimate of $28.00, and a low …

nasdaq.com

44%
OFF

Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?

1 week from now

Nov 14, 2024 · In the third quarter, Hims & Hers subscribers jumped 44% year-over-year to 2 million. The company’s revenue was up 77% year-over-year to $401.6 million, and Hims & …

benzinga.com

89%
OFF

Hims & Hers Health Options Trading: A Deep Dive Into Market

1 week from now

5 days ago · Hims & Hers Health's Current Market Status. Trading volume stands at 6,096,821, with HIMS's price down by -1.89%, positioned at $24.93. RSI indicators show the stock to be …

benzinga.com

43%
OFF

What's Going On With CVS, Humana And UnitedHealth Shares …

1 week from now

5 days ago · Price Action: At the time of publication, CVS stock is trading 7.43% higher at $51.56, Humana shares are trading 7.38% higher at $289.98 and UnitedHealth stock is moving 4.37% …

benzinga.com

$52.14
OFF

What's Going On With CVS Health Stock? - Benzinga

1 week from now

1 day ago · In the the case of CVS Health, which is trading at $52.14 as of publishing time, $100 would buy you 1.92 shares of stock. If you're looking to bet against a company, the process is …

benzinga.com

7%
OFF

What's Going On With Humana Stock? - Benzinga

1 week from now

1 day ago · Humana shares are trading lower by 3.7% during Thursday's session. Shares are lower following UnitedHealth Group's earnings report, reflecting concerns about potential …

benzinga.com

FAQs about What's Going On With Hims & Hers Health Stock? - Benzinga Coupon?

Is hims & hers health (Hims) a good stock to buy?

Hims & Hers Health (HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth company has been growing at a fast rate, making it one of the best stocks to own in healthcare of late. But while the business is growing, investors should be careful not to overlook the challenges the company is facing. ...

Should you buy Hims & hers health (Hims) in 2024?

Rising competition from Amazon may also put pressure on its ability to grow at a high rate and remain profitable. Hims & Hers Health (HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth company has been growing at a fast rate, making it one of the best stocks to own in healthcare of late. ...

What is hims & hers health (Hims)?

Begin your TipRanks Premium journey today. Hims & Hers Health (HIMS) Company Description: Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. ...

Is hims & hers a risky investment?

The stock's high valuation and low margins make Hims & Hers a risky investment to own. Investors may want to consider sitting on the sidelines for now as there could be some tough times ahead for the stock not just this year but over the long haul as well. ...

Is hims & hers a good telehealth stock?

Hims & Hers has grown its business significantly over the years. From less than $150 million in sales in 2020 to more than $1.2 billion in the trailing 12 months, the company has become one of the fastest-growing telehealth stocks to own in recent years. ...

What's going on with hims & hers?

A potentially more significant problem for Hims & Hers is that tech giant Amazon is spending heavily on healthcare, and that could ramp up competition, drastically. ...